Exploring the Versatility of Cyclodextrins in Pharmaceutical Formulations
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 93
Special Issue Editor
Interests: cyclodextrins; polymorphism; crystals; inclusion complexes; calculations; quantum mechanics; GIPAW; GIAO; CASTEP; phase transition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The application of cyclodextrins (CDs) as pharmaceutical excipients is highly appreciated and well-established. Several papers focusing on various beneficial properties of CDs in this field have been published. CDs are commonly applied as drug delivery systems, solubilizers and absorption promoters, agents that improve drug stability, and excipients used for the heat and radiation protection of other molecules and even active pharmaceutical ingredients (APIs).
However, the applications of CDs have several drawbacks. For example, CDs are usually capable of binding only one drug molecule (fully or partially), showing poor drug loading capacity. Additionally, the relatively low stability constants of drug–CD complexes contribute to easy dissociation and release of their contents. However, due to highly reactive hydroxyl groups, CDs can act as polyfunctional monomers. The polymerization of CDs leads to the formation of cyclodextrin-based nanosponges (CDNSs) and other macromolecules.
This Special Issue aims to gather the studies in which particular attention was paid to assessing structural properties, methods of synthesis, and physicochemical analyses of CDs and CD-based materials using various analytical methods, such as DLS, PXRD, TGA, DSC, FT-IR, NMR, and phase solubility studies. Also, due to the significant role of CDs in pharmaceutical research and industry, aspects such as drug loading, drug release studies, and kinetics profile evaluations of drug–CDs complexes are within the scope of this Special Issue.
Original research papers, both experimental and theoretical, communications, and review articles are welcome for this Special Issue.
Dr. Łukasz Szeleszczuk
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cyclodextrins
- CDs
- inclusion complexes
- cyclodextrin-based nanosponges
- excipients
- host–guest complexes
- complexes
